Literature DB >> 12888336

Pyruvate prevents poly-ADP ribose polymerase (PARP) activation, oxidative damage, and pyruvate dehydrogenase deactivation during hemorrhagic shock in swine.

Paul D Mongan1, John Karaian, Brian M Van Der Schuur, Darin K Via, Pushpa Sharma.   

Abstract

The inadequate availability of fuel substrates and sharp decline in cellular ATP have been implicated in a cascade of events associated with cell death and organ failure during hemorrhagic shock (HS). In this in vivo swine model of severe prolonged HS, the effect of exogenous pyruvate administration on various markers of cell damage in brain and liver was examined. Thirty minutes after the start of controlled arterial hemorrhage, 30% sodium pyruvate, 10% saline, or 0.9% saline was administered via jugular vein. Four hours after the initiation of hemorrhage, tissue samples from brain and liver were obtained and examined for the cellular and molecular markers of cellular damage. Results of our study suggest that pyruvate prevents loss of total NAD content, cleavage of poly-ADP ribose polymerase (PARP), and inhibits lipid peroxidation in both the brain and liver of swine during prolonged severe HS. We conclude that there are multiple mechanisms by which pyruvate can possibly prevent cell damage caused during HS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888336     DOI: 10.1016/s0022-4804(03)00148-3

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  13 in total

1.  Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat.

Authors:  Nobuhiro Moro; Richard L Sutton
Journal:  Exp Neurol       Date:  2010-07-27       Impact factor: 5.330

2.  Pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after experimental traumatic brain injury.

Authors:  Nobuhiro Moro; Sima S Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

3.  Metabolic fate of glucose in rats with traumatic brain injury and pyruvate or glucose treatments: A NMR spectroscopy study.

Authors:  Katsunori Shijo; Richard L Sutton; Sima S Ghavim; Neil G Harris; Brenda L Bartnik-Olson
Journal:  Neurochem Int       Date:  2016-12-03       Impact factor: 3.921

4.  Metabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injury.

Authors:  Masamichi Fukushima; Stefan M Lee; Nobuhiro Moro; David A Hovda; Richard L Sutton
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

5.  Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease.

Authors:  Yun-Mi Kim; Su Yeon Choi; Onyou Hwang; Joo-Yong Lee
Journal:  Mol Neurobiol       Date:  2022-09-03       Impact factor: 5.682

6.  Ethyl pyruvate prevents inflammatory responses and organ damage during resuscitation in porcine hemorrhage.

Authors:  WeiHong Dong; Bolin Cai; Geber Peña; Vadim Pisarenko; Gergely Vida; Danielle Doucet; Marlon Lee; Susan Sharpe; Qi Lu; Da-Zhong Xu; Laura Ramos; Edwin A Deitch; Luis Ulloa
Journal:  Shock       Date:  2010-08       Impact factor: 3.454

Review 7.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Role of pyruvate dehydrogenase complex in traumatic brain injury and Measurement of pyruvate dehydrogenase enzyme by dipstick test.

Authors:  Pushpa Sharma; Brandi Benford; Zhao Z Li; Geoffrey Sf Ling
Journal:  J Emerg Trauma Shock       Date:  2009-05

9.  Single sodium pyruvate ingestion modifies blood acid-base status and post-exercise lactate concentration in humans.

Authors:  Robert A Olek; Sylwester Kujach; Damian Wnuk; Radoslaw Laskowski
Journal:  Nutrients       Date:  2014-05-16       Impact factor: 5.717

10.  A unique array of neuroprotective effects of pyruvate in neuropathology.

Authors:  Yuri Zilberter; Olena Gubkina; Anton I Ivanov
Journal:  Front Neurosci       Date:  2015-02-17       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.